Cite
MLA Citation
Dale N Gerding et al.. “Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence.” Clinical infectious diseases, vol. 67, 2018, pp. 649–656. http://access.bl.uk/ark:/81055/vdc_100095323404.0x00001f